Page 53 - GTM-3-3
P. 53

Global Translational Medicine                                         Ocular changes in Alzheimer’s disease



            67.  Frost S, Kanagasingam Y, Sohrabi H,  et  al. Retinal   76.  Den Haan J, van de Kreeke JA, van Berckel BN, et al. Is retinal
               vascular biomarkers for early detection and monitoring of   vasculature a biomarker in amyloid proven Alzheimer’s
               Alzheimer’s disease. Transl Psychiatry. 2013;3(2):e233.  disease? Alzheimers Dement (Amst). 2019;11:383-391.
               doi: 10.1038/tp.2012.150                           doi: 10.1016/j.dadm.2019.03.006
            68.  Shi H, Koronyo Y, Rentsendorj A,  et al. Identification of   77.  Ramrattan RS, Van Der Schaft TL, Mooy CM, de Bruijn WC,
               early pericyte loss and vascular amyloidosis in Alzheimer’s   Mulder PG, de Jong PT. Morphometric analysis of Bruch’s
               disease retina. Acta Neuropathol. 2020;139:813-836.  membrane, the choriocapillaris, and the choroid in aging.
                                                                  Invest Ophthalmol Vis Sci. 1994;35(6):2857-2864.
               doi: 10.1007/s00401-020-02134-w
                                                               78.  Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-
            69.  Sagare AP, Sweeney MD, Makshanoff J, Zlokovic BV.   beta deposits lead to retinal degeneration in a mouse
               Shedding of soluble platelet-derived growth factor   model of Alzheimer disease.  Invest  Ophthalmol Vis Sci.
               receptor-β from human brain pericytes.  Neurosci  Lett.   2008;49(11):5136-5143.
               2015;607:97-101.
                                                                  doi: 10.1167/iovs.08-1849
               doi: 10.1016/j.neulet.2015.09.025
                                                               79.  Jirarattanasopa P, Ooto S, Nakata I, et al. Choroidal thickness,
            70.  Dollery CT, Bulpitt CJ, Kohner EM. Oxygen supply to the   vascular hyperpermeability, and complement factor H in
               retina from the retinal and choroidal circulations at normal   age-related macular degeneration and polypoidal choroidal
               and increased arterial oxygen tensions. Invest Ophthalmol.   vasculopathy.  Invest Ophthalmol Vis Sci. 2012;53(7):
               1969;8(6):588-594.                                 3663-3672.
            71.  Laviers H, Zambarakji H. Enhanced depth imaging-OCT of      doi: 10.1167/iovs.12-9619
               the choroid: A review of the current literature. Graefes Arch
               Clin Exp Ophthalmol. 2014;252(12):1871-1883.    80.  Yoonessi A, Yoonessi A. Functional assessment of magno,
                                                                  parvo and konio-cellular pathways; Current state and
               doi: 10.1007/s00417-014-2840-y                     future clinical applications. J Ophthalmic Vis Res. 2011;6(2):
            72.  Salobrar-García E, de Hoz R, Ramírez AI, et al. Changes in   119-126.
               visual function and retinal structure in the progression of   81.  Rizzo M, Anderson SW, Dawson J, Nawrot M. Vision
               Alzheimer’s disease. PLoS One. 2019;14(8):e0220535.  and cognition in Alzheimer’s disease.  Neuropsychologia.
               doi: 10.1371/journal.pone.0220535                  2000;38(8):1157-1169.
            73.  Choi W, Mohler KJ, Potsaid B, et al. Choriocapillaris and      doi: 10.1016/S0028-3932(00)00023-3
               choroidal microvasculature imaging with ultrahigh speed   82.  Tippett WJ, Sergio LE. Visuomotor integration is impaired
               OCT angiography. PLoS One. 2013;8(12):e81499.      in early stage Alzheimer’s disease. Brain Res. 2006;1102(1):
               doi: 10.1371/journal.pone.0081499                  92-102.
            74.  Bayhan H, Bayhan S, Celikbilek A, et al. Evaluation of the      doi: 10.1016/j.brainres.2006.04.049
               chorioretinal thickness changes in Alzheimer’s disease using   83.  Polo V, Rodrigo MJ, Garcia-Martin E, et al. Visual dysfunction
               spectral‐domain  optical  coherence  tomography.  Clin Exp   and its correlation with retinal changes in patients with
               Ophthalmol. 2015;43(2):145-151.                    Alzheimer’s disease. Eye (Lond). 2017;31(7):1034-1041.
               doi: 10.1111/ceo.12386                             doi: 10.1038/eye.2017.23
            75.  Bulut M, Yaman A, Erol MK, et al. Choroidal thickness in   84.  Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-
               patients with mild cognitive impairment and Alzheimer’s   screening, diagnosis, and management: A  review.  JAMA.
               type dementia. J Ophthalmol. 2016;2016:7291257.    2021;325(2):164-174.
               doi: 10.1155/2016/7291257                          doi: 10.1001/jama.2020.21899


















            Volume 3 Issue 3 (2024)                         14                              doi: 10.36922/gtm.4094
   48   49   50   51   52   53   54   55   56   57   58